TY - JOUR
T1 - Development and validation of a VISA tendinopathy questionnaire for greater trochanteric pain syndrome, the VISA-G
AU - Fearon, Angie
AU - Ganderton, Charlotte
AU - SCARVELL, Jennie
AU - Smith, Paul
AU - Neeman, Teresa
AU - Nash, Clare
AU - Cook, Jill
PY - 2015
Y1 - 2015
N2 - Background: Greater trochanteric pain syndrome (GTPS) is common, resulting in significant pain and disability. There is no condition specific outcome score to evaluate the degree of severity of disability associated with GTPS in patients with this condition. Objective: To develop a reliable and valid outcome measurement capable of evaluating the severity of disability associated with GTPS. Methods: A phenomenological framework using in-depth semi structured interviews of patients and medical experts, and focus groups of physiotherapists was used in the item generation. Item and format clarification was undertaken via piloting. Multivariate analysis provided the basis for item reduction. The resultant VISA-G was tested for reliability with the inter class co-efficient (ICC), internal consistency (Cronbach's Alpha), and construct validity (correlation co-efficient) on 52 naïve participants with GTPS and 31 asymptomatic participants. Results: The resultant outcome measurement tool is consistent in style with existing tendinopathy outcome measurement tools, namely the suite of VISA scores. The VISA-G was found to be have a test-retest reliability of ICC
2,1 (95% CI) of 0.827 (0.638-0.923). Internal consistency was high with a Cronbach's Alpha of 0.809. Construct validity was demonstrated: the VISA-G measures different constructs than tools previously used in assessing GTPS, the Harris Hip Score and the Oswestry Disability Index (Spearman Rho:0.020 and 0.0205 respectively). The VISA-G did not demonstrate any floor or ceiling effect in symptomatic participants. Conclusion: The VISA-G is a reliable and valid score for measuring the severity of disability associated GTPS.
AB - Background: Greater trochanteric pain syndrome (GTPS) is common, resulting in significant pain and disability. There is no condition specific outcome score to evaluate the degree of severity of disability associated with GTPS in patients with this condition. Objective: To develop a reliable and valid outcome measurement capable of evaluating the severity of disability associated with GTPS. Methods: A phenomenological framework using in-depth semi structured interviews of patients and medical experts, and focus groups of physiotherapists was used in the item generation. Item and format clarification was undertaken via piloting. Multivariate analysis provided the basis for item reduction. The resultant VISA-G was tested for reliability with the inter class co-efficient (ICC), internal consistency (Cronbach's Alpha), and construct validity (correlation co-efficient) on 52 naïve participants with GTPS and 31 asymptomatic participants. Results: The resultant outcome measurement tool is consistent in style with existing tendinopathy outcome measurement tools, namely the suite of VISA scores. The VISA-G was found to be have a test-retest reliability of ICC
2,1 (95% CI) of 0.827 (0.638-0.923). Internal consistency was high with a Cronbach's Alpha of 0.809. Construct validity was demonstrated: the VISA-G measures different constructs than tools previously used in assessing GTPS, the Harris Hip Score and the Oswestry Disability Index (Spearman Rho:0.020 and 0.0205 respectively). The VISA-G did not demonstrate any floor or ceiling effect in symptomatic participants. Conclusion: The VISA-G is a reliable and valid score for measuring the severity of disability associated GTPS.
KW - GTPS
KW - Gluteus muscles
KW - Patient outcome assessment
KW - Tendinopathy
UR - http://www.scopus.com/inward/record.url?scp=84951573320&partnerID=8YFLogxK
UR - http://www.mendeley.com/research/development-validation-visa-tendinopathy-questionnaire-greater-trochanteric-pain-syndrome-visag
U2 - 10.1016/j.math.2015.03.009
DO - 10.1016/j.math.2015.03.009
M3 - Article
VL - 20
SP - 805
EP - 813
JO - Musculoskeletal Science and Practice
JF - Musculoskeletal Science and Practice
SN - 1356-689X
IS - 6
ER -